TARIVID 200 MG SOLUTION FOR INTRAVENOUS INFUSION

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

OFLOXACIN 2 MG/ML

MAH:

SANOFI - AVENTIS ISRAEL LTD

ATC_code:

J01MA01

pharmaceutical_form:

SOLUTION FOR INFUSION

administration_route:

I.V

manufactured_by:

SANOFI - AVENTIS DEUTSCHLAND GMBH, GERMANY

therapeutic_group:

OFLOXACIN

therapeutic_indication:

Infections of kidney, urinarty tract, genital organs, respiratory tract, chronic and recurrent ear, nose and throat, skin and soft tissues, bones and joints, bacterial enteritis, abdominal cavity, including pelvis minor and septicemia caused by ofloxacin sensitive microorganisms. Prevention of infections in patients with a signifcant reduction of resistance to infections,

authorization_date:

2010-11-01